Provided by Tiger Trade Technology Pte. Ltd.

Unicycive Therapeutics, Inc.

6.77
+0.04000.59%
Pre-market: 6.900.1300+1.92%08:30 EDT
Volume:221.86K
Turnover:1.51M
Market Cap:145.50M
PE:-4.23
High:6.91
Open:6.88
Low:6.69
Close:6.73
52wk High:11.00
52wk Low:3.71
Shares:21.49M
Float Shares:13.01M
Volume Ratio:0.56
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6020
EPS(LYR):-5.6466
ROE:-102.29%
ROA:-44.23%
PB:3.88
PE(LYR):-1.20

Loading ...

Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 25, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 19, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Correspondence

Form CORRESP - Correspondence
Jul 03, 2024

Major Issues Report

Form 8-K - Current report